Interactions with p300 enhance transcriptional activation by the PDZ-domain coactivator Bridge-1

Journal of Endocrinology

Volumn 187, Issue 2, 2005, Pages 283-292

  Lee, Jee H ^b   Volinic, Jamie L ^b   Banz, Constanze ^b   Yao, Kwok Ming ^a   Thomas, Melissa K ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; CYSTEINE; E1A PROTEIN; GLUTATHIONE TRANSFERASE; HISTIDINE; HISTONE; HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; MUTANT PROTEIN; PDZ PROTEIN; PROTEIN BRIDGE 1; PROTEIN P300; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE DELETION; GENE OVEREXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; IMMUNOPRECIPITATION; MUTAGENESIS; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSCRIPTION INITIATION;

ADENOVIRUS E1A PROTEINS; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE DELETION; GLUTATHIONE TRANSFERASE; HELIX-LOOP-HELIX MOTIFS; HISTONE DEACETYLASES; HYDROXAMIC ACIDS; IMMUNOPRECIPITATION; INSULIN; MUTAGENESIS, SITE-DIRECTED; P300-CBP TRANSCRIPTION FACTORS; POINT MUTATION; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, TERTIARY; PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; YEASTS;

EID: 28044439856     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06305     Document Type: Article

References (34)

1. Andreassen OA, Dedeoglu A, Stanojevic V, Hughes DB, Browne SE, Leech CA, Ferrante RJ, Habener JF, Beal MF & Thomas MK 2002 Huntington's disease of the endocrine pancreas: insulin deficiency and diabetes mellitus due to impaired insulin gene expression. Neurobiology of Disease 11 410-424.
2. Chakrabarti SK, Francis J, Ziesmann SM, Garmey JC & Mirmira RG 2003 Covalent histone modifications underlie the developmental regulation of insulin gene transcription in pancreatic beta cells. Journal of Biological Chemistry 278 23617-23623.
3. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M & Evans RM 1996 Role of CBP/P300 in nuclear receptor signalling. Nature 383 99-103.
4. Chan HM & La Thangue NB 2001 p300/CRP proteins: HATS for transcriptional bridges and scaffolds. Journal of Cell Science 114 2363-2373.
5. Chen J, Halappanavar SS, St-Germain JR, Tsang BK & Li Q 2004 Role of Akt/protein kinase B in the activity of transcriptional coactivator p300. Cellular and Molecular Life Sciences 61 1675-1683.
6. DeMartino GN, Proske RJ, Moomaw CR, Strong AA, Song X, Hisamatsu H, Tanaka K & Slaughter CA 1996 Identification, purification, and characterization of a PA700-dependent activator of the proteasome. Journal of Biological Chemistry 271 3112-3118.
7. Eeckhoute J, Formstecher P & Laine B 2001 Maturity-onset diabetes of the young type 1 (MODY1)-associated mutations R154X and E2767Q in hepatocyte nuclear factor 4 alpha (HNF4 alpha) gene impair recruitment of p300, a key transcriptional coactivator. Molecular Endocrinology 15 1200-1210.
8. Fajans SS, Bell GI & Polonsky KS 2001 Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. New England Journal of Medicine 345 971-980.
9. Giles RH, Peters DJ & Breuning MH 1998 Conjunction dysfunction: CBP/p300 in human disease. Trends in Genetics 14 178-183.
10. Golemis EA, Gyuris J & Brent R 1994 Interaction trap/two-hybrid system to identify interacting proteins, unit 13.14. In Current Protocols in Molecular Biology, pp 13.14.11.13.14.17, Eds FM Ausubel, R Brent, RE Kingston, DD Moore, JG Seidman, JA Smith & K Struhl. New York: Wiley.
11. Gonzales F, Delahodde A, Kodadek T & Johnston SA 2002 Recruitment of a 19S proteasome subcomplex to an activated promoter. Science 296 548-550.
12. Grossman SR, Deato ME, Brignone C, Chan HM, King AL, Tagami H, Nakatani Y & Livingston DM 2003 Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 300 342-344.
13. Grossman SR, Perez M, Kung AL, Joseph M, Mansur C, Xiao ZX, Kumar S, Howley PM & Livingston DM 1998 p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Molecular Cell 2 405-415.
14. Iyer NG, Ozdag H & Caldas C 2004 p300/CBP and cancer. Oncogene 23 4225-4231.
15. Kurihara N, Ishizuka S, Demulder A, Menaa C & Roodman GD 2004 Paget's disease - a VDR coactivator disease? Journal of Steroid Biochemistry and Molecular Biology 89-90 321-325.
16. Li Q, Su A, Chen J, Lefebvre YA & Hache RJ 2002 Attenuation of glucocorticoid signaling through targeted degradation of p300 via the 26S proteasome pathway. Molecular Endocrinology 16 2819-2827.
17. Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, Saad M, Warram JH, Montminy M & Krolewski AS 1999 Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nature Genetics 23 323-328.
18. Mosley AL, Corbett JA & Ozcan S 2004 Glucose regulation of insulin gene expression requires the recruitment of p300 by the beta-cell-specific transcription factor Pdx-1. Molecular Endocrinology 18 2279-2290.
19. Ohana B, Moore PA, Ruben SM, Southgate CD, Green MR & Rosen CA 1993 The type 1 human immunodeficiency virus Tat binding protein is a transcriptional activator belonging to an additional family of evolutionarily conserved genes. PNAS 90 138-142.
20. Poizat C, Sartorelli V, Chung G, Kloner RA & Kedes L 2000 Proteasome-mediated degradation of the coactivator p300 impairs cardiac transcription. Molecular and Cellular Biology 20 8643-8654.
21. Qiu Y, Sharma A & Stein R 1998 p300 mediates transcriptional stimulation by the basic helix-loop-helix activators of the insulin gene. Molecular and Cellular Biology 18 2957-2964.
22. Qiu Y, Guo M, Huang S & Stem R 2002 Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E47. Molecular and Cellular Biology 22 412-420.
23. Roelfsema JH, White SJ, Ariyurek Y, Bartholdi D, Niedrist D, Papadia F, Bacino CA, den Dunnen JT, van Ommen GJ, Breuning MH et al. 2005 Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. American Journal of Human Genetics 76 572-580.
24. Savkur RS, Bramlett KS, Clawson D & Burris TP 2004 Pharmacology of nuclear receptor-coregulator recognition. Vitamins and Hormones 68 145-183.
25. Shang Y & Brown M 2002 Molecular determinants for the tissue specificity of SERMs. Science 295 2465-2468.
26. Sharma A, Moore M, Marcora E, Lee JE, Qiu Y, Samaras S & Stein R 1999 The NeuroD1/BETA2 sequences essential for insulin gene transcription colocalize with those necessary for neurogenesis and p300/CREB binding protein binding. Molecular and Cellular Biology 19 704-713.
27. Stanojevic V, Habener JF & Thomas MK 2004 Pancreas duodenum homeobox-1 transcriptional activation requires interactions with p300. Endocrinology 145 2918-2928.
28. Stanojevic V, Yao KM & Thomas MK 2005 The coactivator Bridge-1 increases transcriptional activation by pancreas duodenum homeobox-1 (PDX-1). Molecular Cellular Endocrinology 237 67-74.
29. Stein RW, Corrigan M, Yaciuk P, Whelan J & Moran E 1990 Analysis of E1A-mediated growth regulation functions: binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity. Journal of Virology 64 4421-4427.
30. Thomas MK, Yao KM, Tenser MS, Wong GG & Habener JF 1999 Bridge-1, a novel PDZ-domain coactivator of E2A-mediated regulation of insulin gene transcription. Molecular and Cellular Biology 19 8492-8504.
31. Vo N & Goodman RH 2001 CREB-binding protein and p300 in transcriptional regulation. Journal of Biological Chemistry 276 13505-13508.
32. Volinic J, Lee JH, Eto K, Kaur V & Thomas MK 2006 Overexpression of the coactivator Bridge-1 results in insulin deficiency and diabetes. Molecular Endocrinology (2005 Aug 11 [Epub ahead of print]).
33. Watanabe TX, Saito A, Suzuki M, Fujiwara T, Takahashi E, Slaughter CA, DeMartino GN, Hendil KB, Chung CH, Tanahashi N et al. 1998 cDNA cloning and characterization of a human proteasomal modulator subunit, p27. Genomics 50 241-250.
34. Yao TP, Oh SP, Fuchs M, Zhou ND, Ch'ng LE, Newsome D, Bronson RT, Li E, Livingston DM & Eckner R 1998 Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300. Cell 93 361-372.